Sign in

You're signed outSign in or to get full access.

Russell Low

Russell Low

President and Chief Executive Officer at AXCELIS TECHNOLOGIESAXCELIS TECHNOLOGIES
CEO
Executive
Board

About Russell Low

Russell J. Low, Ph.D., is President, CEO, and director of Axcelis Technologies (since May 2023), age 54, with prior leadership in engineering and customer operations across ion implant and semiconductor capital equipment companies . Under his tenure in 2024, Axcelis delivered revenue of $1.02B and EPS of $6.15 amid an industry downturn, with higher gross margins and strong free cash flow; five‑year cumulative TSR since 2019 outperformed the SOXX index . 2024 Say‑on‑Pay support was 93.8%, indicating investor alignment with pay design .

Past Roles

OrganizationRoleYearsStrategic impact
Axcelis TechnologiesPresident & CEOMay 2023–presentLeads strategy following period of improving financial performance and market share .
Axcelis TechnologiesEVP, Global Customer & Engineering Operations2021–May 2023Drove customer operations and engineering during market share gains .
Axcelis TechnologiesEVP, Engineering2016–2021Led engineering for Purion platform innovations .
Veeco InstrumentsVP Engineering, MOCVD BU; Sr. Director Eng., MBE BU2012–2013 (Sr. Dir. 2012; VP 2013)Led compound semiconductor tool engineering .
Varian Semiconductor Equipment AssociatesVarious, incl. Director of Technology2003–2012Technology leadership in implant systems .
Applied MaterialsEngineering roles (thermal processing and ion implant divisions)1997–2003Engineering roles across implant and thermal process .

External Roles

OrganizationRoleYears
SEMI InternationalNorth American Advisory Board (NAAB)Not disclosed
Massachusetts High Tech CouncilMemberNot disclosed
Other public company boardsNot currently serving

Fixed Compensation

Multi-year CEO compensation snapshot (Summary Compensation Table):

Metric202220232024
Base salary ($)372,692 530,102 633,000
Stock awards ($)663,254 3,076,368 3,217,435
Non‑equity incentive plan compensation ($)416,707 519,068 431,706
All other compensation ($)9,150 9,900 11,367
Total ($)1,461,804 4,135,438 4,293,508

2024 annual cash incentive design and outcome:

Item2024 Plan
Target bonus % of base100% (CEO)
Company metrics (weight)Revenue (50%), Operating profit (25%), Gross margin (25%)
Full‑year targets/goalpostsSee table for 25%/100%/200% score lines
Actual 2024 resultsRevenue $1,017.9M; Op profit $223.4M; Gross margin 45.0%
Plan score and payout68.2% funding; CEO bonus paid $431,706

Performance Compensation

2024 Axcelis Management Incentive (AMI) metrics and scoring:

MetricTarget basisActualWeightScoreWeighted score
Revenue ($M)25%/100%/200% score posts per profit plan 1,017.9 50% 71.5% 35.8%
Operating profit before plan ($M)25%/100%/200% posts per plan 223.4 25% 60.2% 15.0%
Gross margin (pre‑plan)25%/100%/200% posts per plan 45.0% 25% 69.7% 17.4%
Total68.2%

2024 Performance RSUs (PRSUs):

ComponentDesignOutcome
Structure10 operational goals; two weighted 25% each, eight weighted 12.5% each; max earn 150% of target
Achieved10/10 goals achieved; 150% earned
Vesting50% of earned PRSUs vested Feb 28, 2025; remaining 50% vest Feb 28, 2026, continued service required

2024 time‑based RSUs:

Grant dateUnitsVesting
May 15, 202414,244 service‑vesting RSUs (CEO) 25% annually on each of first four anniversaries (through May 2028)

Equity Ownership & Alignment

ItemDetail
Beneficial ownership (3/17/2025)40,632 shares owned; 10,076 shares subject to exercisable rights within 60 days; total 50,708; <1% of class
Unvested RSUs at 12/31/202436,351 service‑based RSUs ($2,539,844 at $69.87); 14,244 target PRSUs ($995,228 at $69.87)
Hedging/pledgingProhibited for directors/officers; none of Low’s shares/rights are pledged or in margin
Stock ownership guidelinesCEO must hold shares equal to 3x base salary; 5 years to comply

Upcoming vesting (potential supply/insider selling pressure):

TrancheVest dateSharesType
PRSU (50% of 150% earned)Feb 28, 202510,683 (50% of 21,366) PRSU vested
RSU (25% of 2024 service grant)May 15, 20253,561 (25% of 14,244) Time‑based RSU
PRSU (remaining 50%)Feb 28, 202610,683 PRSU vested
RSU (annual tranches)May 15, 2026–20283,561 per year through 2028 Time‑based RSU

Note: 2023 PRSUs (135% earned) fully vested by Feb 28, 2025, adding to near‑term supply .

Alignment observations:

  • CEO ownership and guideline: at the 12/31/2024 close ($69.87), 40,632 shares approximate $2.84M of value versus a 3x base salary requirement of ~$1.90M, indicating likely compliance as of that date (calculation using disclosed share count and price) .

Employment Terms

TermKey provisions
Employment agreementEffective May 2023; minimum base $633,000 (from 2024), target bonus 100% of base; auto‑renews yearly unless notice by April 1
Severance (without cause/Good Reason)24 months base + 24 months bonus proxy (greater of prior‑year bonus% or 25% of base); full equity acceleration; up to 18 months COBRA
Estimated separation (12/31/2024)Cash $2,690,883; equity acceleration value $2,046,338; COBRA $56,534; total $4,793,755
Change‑of‑Control (double‑trigger)2x (base + target bonus) lump sum; equity acceleration valued per 280G methods; no excise tax gross‑up
ClawbackDodd‑Frank compliant 3‑year restatement recoupment; plus 12 months of incentive comp for policy violations
PerquisitesNo executive perquisites; standard 401(k) match and benefits as for employees

Board Governance

  • Board/Director service: Director since 2023; not independent (management director) .
  • Leadership/independence: Independent Chair (since May 2024) and regular executive sessions of independent directors; all committee members meet enhanced independence standards .
  • Committees: Dr. Low is not listed on Audit, Compensation, Nominating & Governance, or Technology committees (non‑independent CEO typically does not serve) .
  • Attendance: No director below 75% attendance in 2024; Board/committee attendance averaged 97% .
  • Policies: No hedging/pledging; no option repricing; double‑trigger CoC; no excise tax gross‑ups; robust stock ownership guidelines .

Compensation Structure Analysis

  • Mix and leverage: In 2024, 50% of CEO total target pay was performance‑based (annual cash + PRSUs); equity comprised 70% of CEO target compensation, emphasizing long‑term alignment .
  • 2024 outcomes: Below‑target AMI payout at 68.2% due to revenue, profit, and margin shortfalls; 2024 PRSUs paid at 150% on operational goals, driving realized CEO pay to 113% of target (assumes continued vesting) .
  • Peer benchmarking: Committee targets median market pay; peer group constructed and refreshed with Pearl Meyer; 2025 peer set expanded (added Entegris, IPG Photonics, MKS, Novanta, OSI; removed 3D Systems, Varex) .
  • Governance checks: Strong Say‑on‑Pay (93.8% in 2024), clawback expanded in 2023, prohibition on repricing and perqs, and double‑trigger CoC support alignment and risk control .

Say‑on‑Pay & Shareholder Feedback

  • Say‑on‑Pay approval: 93.8% support at 2024 annual meeting; Board views as validation of program .
  • Engagement: Active IR program; 18 conferences/NDRs in 2024; message emphasized resilient profitability, balance sheet strength, and leadership in power devices .

Risk Indicators & Red Flags

  • Related parties: No related‑party transactions requiring disclosure in 2024 .
  • Hedging/pledging: Prohibited and none reported; Section 16 compliance confirmed for 2024 .
  • Equity plan features: No repricing; multi‑year vesting minimums; double‑trigger acceleration in cash deals; 2012 EIP share increase proposal keeps plan voting power dilution under 11% (burn rate well below ISS benchmark) .
  • Legal/compliance: One HR policy incident remediated in 2024; manager resigned; otherwise no material compliance issues reported .

Investment Implications

  • Alignment and incentives: High equity weighting with PRSUs tied to operational milestones, strict ownership guidelines, and prohibitions on hedging/pledging point to strong alignment; robust Say‑on‑Pay support reduces governance overhang .
  • Retention and transition: CEO severance (24 months cash + full equity acceleration) and double‑trigger CoC (2x cash + equity) mitigate retention risk but create potential downside protection; clawback coverage moderates risk .
  • Trading supply watch: Meaningful near‑term vestings (Feb/May 2025) could add technical selling pressure if shares are sold to cover taxes/liquidity needs; monitor Form 4s around these dates (10,683 PRSUs vested Feb 2025; ~3,561 RSUs vest May 2025) .
  • Performance execution: 2024 under‑target AMI outcome vs. 150% PRSU earn suggests operational execution momentum even as macro softness pressures financials; maintaining revenue/profit traction will be key to future AMI/PRSUs and sentiment .